![Overview of Organization ,[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recomendados
Mais conteúdo relacionado
Semelhante a testsgl;mdlfmb
Semelhante a testsgl;mdlfmb (20)
Mais de Success_wisdom
Mais de Success_wisdom (7)
Último
Último (20)
testsgl;mdlfmb
- 1. vxVistA V0.9 Mark Byers, President DSS, Inc., The VistA Experts April 20, 2006
Notas do Editor
- 12/03/09
- 12/03/09
- 12/03/09
- 12/03/09
- 12/03/09
- 12/03/09 Several areas of VistA are antiquated. There is a legitimate reason VA is attempting to modernize VistA. The perceived need to scrap VistA is questionable, however, many areas have been neglected for years and need to be overhauled. Prioritizing the necessary enhancements will be based upon immediate need. The U.S. health care market is rapidly changing in order to emulate the success of the VA in improving patient quality and holding down cost. Changes will include governmental compliance with yet to be approved standards which we will have no input.
- 12/03/09 Keeping the cost low enough to allow less affluent medical facilities to implement vxVistA, yet high enough to allow DSS to afford to begin further modernization of VistA. VOE has brought forth the perception that VistA is “free”. It may be less expensive than Cerner or NextGen, however, it isn’t free. Performing the development needed to commercialize VistA is expensive. Supporting commercial VistA customers is expensive. Keeping VistA customer’s database current with FOIA patches and with our own changes is expensive. Product liability insurance is expensive. This same “free” perception has also put downward pressure on implementation and support fees. The successful commercial HIS and practice vendors charge a license fee for a reason. They need the money in order to survive in a highly competitive market. Without a licensing fee for FOIA VistA VSA members are forced to generate their revenue from implementation and support services, and add on product licensing. The market needs to understand that VSA members have to produce revenue in order to survive in this market. This is a marketing challenge for the members and for VSA as a whole. VistA is affordable, however, it isn’t free.
- 12/03/09 DSS supports Hui OpenVista because Hui is more neutral than any other viable entity. DSS and MedSphere are not neutral. Hui is a joint venture between DoD and VA and has had a long-term cooperative relationship with the VHA hierarchy. Hui OpenVista will allow other vendors to take advantage of an updated and improved commercial version of FOIA VistA. Over time, several VSA members and other parties will provide enhancements to a common open source code base. Hui OpenVista is protected with an open source license, Berkeley, which will allow other parties (Blue Cliff, DSS, MedSphere, Sea Island Systems, etc…) to bring to the market their own commercialized version of VistA. It will give them the latitude to decide what they want to offer to the world as an improvement to core open source VistA.
- The VSA is a value marketing tool for its members. The major HIS and practice system vendors spend millions of dollars annually marketing their products to U.S. health care market. The majority of VSA’s members are not capable of matching the marketing efforts of our competitors. VSA has the ability to become a public voice for its members. Many of our competitors are billion dollar companies who lobby the federal and state governments. The next 3 years will become foundation years for all of us. In some ways we are already late from the starting blocks. I don’t believe VSA or any its members are currently members of CCHIT. Federal and state laws are being enacted which will greatly affect many VSA members. The VSA’s trade association status should help give us a greater voice in the ground work legislation being considered today. As it is today, we are definitely along for the ride. Hopefully it will not be a ride over a cliff.